Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centre Européen d'Étude du Diabète (CeeD) is a French research organization dedicated to the study and treatment of diabetes and its associated complications. Based in Strasbourg, CeeD focuses on three main pillars: fundamental research, clinical application, and patient education. The center is internationally recognized for its expertise in pancreatic islet transplantation and the development of a bioartificial pancreas. CeeD's research also explores the molecular mechanisms of insulin resistance and the prevention of chronic diabetic complications such as retinopathy and nephropathy. Through its spin-off companies and academic partnerships, the center translates laboratory discoveries into innovative therapeutic solutions for diabetic patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre Européen d'Étude du Diabète.